We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Cardiac Defibrillator Implanted Under Skin Much Safer for Patients

By HospiMedica International staff writers
Posted on 02 May 2022
Print article
Image: Subcutaneous defibrillator being implanted in a patient (Photo courtesy of Hamilton Health Sciences)
Image: Subcutaneous defibrillator being implanted in a patient (Photo courtesy of Hamilton Health Sciences)

Implantable cardioverter defibrillators (ICDs) improve survival of patients with heart conditions but can cause perioperative complications, including perforation of heart muscle or lungs, and blood clotting in veins. Now, a new type of cardiac defibrillator has been found to significantly reduce major complications for patients.

The traditional defibrillator, the transvenous ICD (TV-ICD), features a lead (a flexible wire coated with insulation) placed in the heart or the heart’s network of blood vessels. Researchers at the Population Health Research Institute (PHRI, Hamilton, ON, Canada) have demonstrated that a different type of ICD - the subcutaneous ICD (S-ICD) – in which the lead is implanted under the skin, just below the patient’s armpit, and runs along the breastbone. The S-ICD does not come into contact with any blood vessels.

Their study found that by eliminating all intra-vascular and intra-cardiac components of the ICD, the S-ICD prevents most lead-related perioperative complications, including nearly all complications which can lead to death. The study followed patients for six months after their device was implanted in 544 patients (one-quarter female) at 14 clinical sites in Canada. Half of the patients were randomized to an S-ICD; the other half to a TV-ICD. The team found that S-ICD reduced the risk of lead-related complications by 92%. Younger patients are usually under-represented in ICD trials; ATLAS S-ICD included ICD-eligible patients 18 to 60 years old (average age of 49) who had a cardiogenetic syndrome or were at high risk for lead-related complications. Follow-up of participants of ATLAS S-ICD is ongoing.

“We need to increase the statistical power of the trial to assess the comparative rates of inappropriate shocks and failed appropriate shocks, as well as the impact of ICD type on tricuspid insufficiency and heart failure,” said PHRI Senior Scientist Jeff Healey.

Related Links:
PHRI 

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Plasma Freezer
iBF125-GX
New
Digital Radiographic System
OMNERA 300M

Print article

Channels

Critical Care

view channel
Image: The BrioVAD System featuring the innovative BrioVAD Pump (Photo courtesy of BrioHealth Solutions)

Innovative Ventricular Assist Device Provides Long-Term Support for Advanced Heart Failure Patients

Advanced heart failure represents the final stages of heart failure, where the heart’s ability to pump blood effectively is severely compromised. This condition often results from underlying health issues... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.